Phathom Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript
Okay. Good morning, everyone. I'm Paul Choi. I cover the small and mid-cap biotechnology sector here at Goldman Sachs. Before we begin (inaudible) disclosures regarding (inaudible) disclosures are available that allow us (inaudible).
However, they are available on our research portal for your information. Goldman Sachs only undertakes us under the assumption that any third-party speaker here today will not provide any confidential or material nonpublic information.
Additionally, the views expressed by third parties do not necessarily reflect those of Goldman Sachs. And with that, we'll continue. It's my pleasure to welcome Phathom Pharmaceuticals here. We're joined by the senior management team. And starting on my left is Martin. Then, to my immediate right, at the far end, sorry, we have Azmi, Molly and Terrie.
What we'll do is let Terrie kick it off with some opening remarks, and then we'll get into Q&A.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
